| 12.04 -0.01 (-0.08%) | 09-11 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 14.43 | 1-year : | 15.23 |
| Resists | First : | 12.36 | Second : | 13.03 |
| Pivot price | 12.2 |
|||
| Supports | First : | 11.26 | Second : | 9.36 |
| MAs | MA(5) : | 12.2 |
MA(20) : | 12.02 |
| MA(100) : | 11.53 |
MA(250) : | 11.52 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.3 |
| %K %D | K(14,3) : | 39.7 |
D(3) : | 47.9 |
| RSI | RSI(14): 52.9 |
|||
| 52-week | High : | 14.67 | Low : | 9.22 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ MED ] has closed above bottom band by 30.4%. Bollinger Bands are 58.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 12.21 - 12.29 | 12.29 - 12.36 |
| Low: | 11.71 - 11.83 | 11.83 - 11.92 |
| Close: | 11.88 - 12.04 | 12.04 - 12.16 |
Medifast, Inc., through its various divisions, develops and provides a range of consumable health and nutritional items tailored for weight loss, weight management, and general wellness. These products are distributed across the United States and the Asia-Pacific region. Their extensive portfolio encompasses snack bars, savory bites, cereals, drinks, substantial meal choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, baked goods, and soups. These offerings are marketed under proprietary brands like OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home. The company facilitates sales primarily through direct e-commerce transactions. Established in 1980, Medifast, Inc. maintains its corporate headquarters in Baltimore, Maryland.
Sun, 06 Sep 2026
BlackRock Inc. Makes New Investment in Medifast Inc $MED - MarketBeat
Fri, 04 Sep 2026
Medifast's 3.0 Strategy Takes Shape: Can It Restore Profitable Growth? - TradingView
Fri, 04 Sep 2026
Medifast (MED) Down 5.1% Since Last Earnings Report: Can It Rebound? - Eastern Progress
Wed, 02 Sep 2026
Why Is Medifast (MED) Down 7.6% Since Last Earnings Report? - Eastern Progress
Fri, 28 Aug 2026
Medifast (NYSE:MED) Director Purchases 43,150 Shares - MarketBeat
Fri, 28 Aug 2026
Medifast (NYSE: MED) director adds 43K shares in open-market buy - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NYSE
|
|
|
Sector:
Consumer Cyclical
|
|
|
Industry:
Personal Products & Services
|
|
| Shares Out | 11 (M) |
| Shares Float | 8 (M) |
| Held by Insiders | 4.1 (%) |
| Held by Institutions | 75.8 (%) |
| Shares Short | 1,820 (K) |
| Shares Short P.Month | 1,640 (K) |
| EPS | -2.33 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 18.98 |
| Profit Margin | -8.1 % |
| Operating Margin | -5.7 % |
| Return on Assets (ttm) | -4.6 % |
| Return on Equity (ttm) | -12.5 % |
| Qtrly Rev. Growth | -27.7 % |
| Gross Profit (p.s.) | 19.62 |
| Sales Per Share | 28.34 |
| EBITDA (p.s.) | -0.51 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 9 (M) |
| Levered Free Cash Flow | 11 (M) |
| PE Ratio | -5.17 |
| PEG Ratio | 0.9 |
| Price to Book value | 0.63 |
| Price to Sales | 0.42 |
| Price to Cash Flow | 15.31 |
| Dividend | 1.64 |
| Forward Dividend | 0 |
| Dividend Yield | 13.7% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|